Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients [NA]
Phase II investigation on prostate artery embolization before radical prostatectomy in prostate cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide [Phase 2]
Phase 2 trial comparing cabazitaxel versus switch to alternative AR-targeted therapy (enzalutamide or abiraterone) in metastatic castration-…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating cixutumumab plus temsirolimus in metastatic prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A registry study update on sipuleucel-T therapy in men with advanced prostate cancer, with completed status and results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Focal Prostate Radio-Frequency Ablation [NA]
Clinical trial update indicating completed study on focal prostate radio-frequency ablation for prostate cancer with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating Oncoxin-Viusid in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer [Phase 2]
Phase 2 trial comparing Radium Ra-223 with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer; comple…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study [Phase 2]
Results from a Phase 2 pilot trial evaluated subharmonic ultrasound imaging for detecting high-grade prostate cancer. The study was conducte…
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON
A completed safety study evaluating FIRMAGON in patients with advanced prostate cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy [Phase 3]
Phase 3 trial of orteronel maintenance therapy in metastatic castration-resistant prostate cancer patients who had non-progressive disease a…
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and cetuximab in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Improving Erectile Function and Quality of Life After Prostate Cancer Treatment [NA]
Clinical trial update related to erectile function and quality of life after prostate cancer treatment; status terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy [NA]
A completed clinical trial comparing transperineal targeted biopsy with standard transrectal biopsy for detecting clinically significant pro…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer [Phase 2]
Phase 2 trial evaluating stereotactic ablative radiotherapy (SABR) for low risk prostate cancer using an injectable rectal spacer; study sta…
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: PSMA PET/CT for Prostate Cancer [Phase 2]
Phase 2 trial update on PSMA PET/CT for prostate cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer [NA]
A randomized trial of image-guided stereotactic radiation therapy for prostate cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: 18F-NaF PET Imaging for Bone Scintigraphy [Phase 3]
Phase 3 trial update on 18F-NaF PET imaging for bone scintigraphy in patients with bone metastases from breast or prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: 18F-DCFBC PET/CT in Prostate Cancer [EARLY_Phase 1]
A Phase 1 study evaluating 18F-DCFBC PET/CT for prostate cancer has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer [Phase 1]
Phase 1 safety and tolerability study of MDV3100 (enzalutamide) in combination with docetaxel in men with advanced prostate cancer completed…
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: EXTEND Exercise Trial [Phase 2]
Phase 2 clinical trial update for the EXTEND Exercise Trial in non-metastatic hormone-naïve prostate cancer; results have been completed and…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer [Phase 3]
Phase 3 trial evaluating the effect of Enantone LP 11.25 mg (leuprorelin) on histological progression in indolent prostate cancer; study com…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer [Phase 1, Phase 2]
A study evaluating two different doses of Revlimid in biochemically relapsed prostate cancer (Phase 1/2) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
A completed clinical trial update regarding Leuplin PRO for Injection Kit 22.5 mg for prostate cancer, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer [Phase 3]
A Phase 3 trial evaluating 99mTc-MIP-1404 SPECT/CT imaging in men with biopsy-proven low-grade prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer [Phase 2]
Phase 2 clinical trial checking intraprostatic PRX302 injections for localized prostate cancer has completed.